HU6 for non-alcoholic fatty liver disease

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 7 Aug 2023: Trial registered, NCT05979779
  2. 5 Sep 2023: Trial started, NCT05979779

The trials

NCT05979779: Ph 2 Study of the Safety and Efficacy of Three HU6 Dose Levels and Placebo in Nonalcoholic Steatohepatitis

State
Under way
Phase
Phase 2
People
219 taking part
Started
5 Sep 2023
Primary completion
21 Jan 2025
Arms
Active Treatment: HU6 Planned doses of HU6
Results
None posted
  1. 7 Aug 2023: Trial registered
  2. 5 Sep 2023: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.